INFORMATION:
- The product (substance) is not a food or dietary supplement, and is not suitable for human consumption.
- Keep out of the reach of children.
- Keep the container tightly closed.
- Store in a dry, cool, shaded place; protect from moisture.
- Store only in original container.
- Avoid contact during pregnancy and lactation.
- Consult a physician if you feel unwell or have adverse reactions related to contact.
A peptide with neuroprotective properties and tonic effects on neurotransmitters. Its action is based on blocking TREK-1 potassium ion channels, TREK-1 is located in areas of the brain that regulate emotion, memory and cognitive function, which contributes to its antidepressant properties. What’s more, its potential for action also hooks into methods of aiding recovery after stroke and in the context of neurodegenerative diseases such as Alzheimer’s. It may make a good combination along with P-21.
Its effects can be felt much faster than when using antidepressants. PE-22-28 stands out in this aspect because it seems to affect neurogenesis in just a few days. Neurogenesis is the growth of new neurons, which translates into effective relief of depression symptoms. Unlike antidepressants, PE-22-28 does not impair sleep and has no negative withdrawal effects.
In addition, it exhibits antimicrobial activity – it interferes with the interaction of microorganisms with cell membranes. Its potential for action includes fungi, bacteria and reduction of inflammation. It is also in clinical trials for the treatment of infectious diseases caused by antibiotic-resistant bacteria. It effectively helps fight autoimmune diseases. In addition, the peptide triggers apoptosis in cancer cells and inhibits their further formation.
